Eric Easom

Insider Reports History

Entity
Individual
Location
171 Forest Ln., Menlo Park, CA
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Easom:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Chief Executive Officer, Director Common Stock 101K $1.93M $19.11 Mar 15, 2024 Direct
AN2 Therapeutics, Inc. Chief Executive Officer, Director Stock Option (right to buy) 198K Mar 15, 2024 Direct

Insider Reports Filed by Eric Easom

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 1 $0 4/A Mar 29, 2024 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Mar 15, 2024 2 $0 4 Mar 18, 2024 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Jan 2, 2024 1 -$55.8K 4 Jan 4, 2024 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. May 15, 2023 1 $53.8K 4 May 15, 2023 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Feb 23, 2023 1 $0 4 Feb 24, 2023 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Nov 10, 2022 2 -$68K 4 Nov 14, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Nov 8, 2022 3 -$268K 4 Nov 9, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Nov 3, 2022 5 -$558K 4 Nov 7, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Oct 31, 2022 2 -$64.6K 4 Nov 2, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Oct 27, 2022 2 -$39.6K 4 Oct 28, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Oct 24, 2022 4 -$147K 4 Oct 26, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Oct 20, 2022 4 -$350K 4 Oct 24, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Mar 29, 2022 2 $0 4 Mar 31, 2022 Chief Executive Officer, Director
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Chief Executive Officer, Director